Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Le

Showing results (171-180 of 312) with videos related to

Pageof 32
Sort By:
Vaccine|March 26, 2015
Bacterial phospholipases C as vaccine candidate antigens against cystic fibrosis respiratory pathogens: the Mycobacterium abscessus modelVincent Le Moigne, Martin Rottman, Céline Goulard, et al.
Data in Brief|November 23, 2020
Data on prognostic factors associated with 3-month and 1-year mortality from infective endocarditisMagali Collonnaz, Marie-Line Erpelding, François Alla, et al.
Annals of Epidemiology|September 20, 2020
Impact of referral bias on prognostic studies outcomes: insights from a population-based cohort study on infective endocarditisMagali Collonnaz, Marie-Line Erpelding, François Alla, et al.
European Heart Journal|October 17, 2006
Diabetes mellitus and infective endocarditis: the insulin factor in patient morbidity and mortalityXavier Duval, François Alla, Thanh Doco-Lecompte, et al.
European Heart Journal|February 12, 2009
The impact of valve surgery on short- and long-term mortality in left-sided infective endocarditis: do differences in methodological approaches explain previous conflicting results?Aurélie Bannay, Bruno Hoen, Xavier Duval, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 1, 2005
T-Cell surface CCR5 density is not correlated with hepatitis severity in hepatitis C virus/HIV-coinfected individuals: implications for the therapeutic use of CCR5 antagonistsThierry Vincent, Pierre Portales, Vincent Baillat, et al.
The Journal of Antimicrobial Chemotherapy|September 16, 2016
Failure to achieve immunological recovery in HIV-infected patients with clinical and virological success after 10 years of combined ART: role of treatment courseFrançois Raffi, Vincent Le Moing, Alex Assuied, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 6, 2003
Plasma levels of indinavir and nelfinavir at time of virologic response may have a different impact on the risk of further virologic failure in HIV-infected patientsVincent Le Moing, Gilles Peytavin, Valérie Journot, et al.
Antiviral Therapy|November 21, 2007
The effect of depressive symptoms at ART initiation on HIV clinical progression and mortality: implications in clinical practiceVirginie Villes, Bruno Spire, Charlotte Lewden, et al.
Infectious Diseases Now|February 10, 2025
Real-world use, effectiveness, and safety of ceftazidime-avibactam: Results of the French cohort OZAVIELionel Piroth, Virginie Vitrat, Vincent Le Moing, et al.
Pageof 32

Showing results (171-180 of 312) with videos related to

Sort By:
Pageof 32
Vaccine|March 26, 2015
Bacterial phospholipases C as vaccine candidate antigens against cystic fibrosis respiratory pathogens: the Mycobacterium abscessus modelVincent Le Moigne, Martin Rottman, Céline Goulard, et al.
Data in Brief|November 23, 2020
Data on prognostic factors associated with 3-month and 1-year mortality from infective endocarditisMagali Collonnaz, Marie-Line Erpelding, François Alla, et al.
Annals of Epidemiology|September 20, 2020
Impact of referral bias on prognostic studies outcomes: insights from a population-based cohort study on infective endocarditisMagali Collonnaz, Marie-Line Erpelding, François Alla, et al.
European Heart Journal|October 17, 2006
Diabetes mellitus and infective endocarditis: the insulin factor in patient morbidity and mortalityXavier Duval, François Alla, Thanh Doco-Lecompte, et al.
European Heart Journal|February 12, 2009
The impact of valve surgery on short- and long-term mortality in left-sided infective endocarditis: do differences in methodological approaches explain previous conflicting results?Aurélie Bannay, Bruno Hoen, Xavier Duval, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 1, 2005
T-Cell surface CCR5 density is not correlated with hepatitis severity in hepatitis C virus/HIV-coinfected individuals: implications for the therapeutic use of CCR5 antagonistsThierry Vincent, Pierre Portales, Vincent Baillat, et al.
The Journal of Antimicrobial Chemotherapy|September 16, 2016
Failure to achieve immunological recovery in HIV-infected patients with clinical and virological success after 10 years of combined ART: role of treatment courseFrançois Raffi, Vincent Le Moing, Alex Assuied, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 6, 2003
Plasma levels of indinavir and nelfinavir at time of virologic response may have a different impact on the risk of further virologic failure in HIV-infected patientsVincent Le Moing, Gilles Peytavin, Valérie Journot, et al.
Antiviral Therapy|November 21, 2007
The effect of depressive symptoms at ART initiation on HIV clinical progression and mortality: implications in clinical practiceVirginie Villes, Bruno Spire, Charlotte Lewden, et al.
Infectious Diseases Now|February 10, 2025
Real-world use, effectiveness, and safety of ceftazidime-avibactam: Results of the French cohort OZAVIELionel Piroth, Virginie Vitrat, Vincent Le Moing, et al.
Pageof 32